Literature DB >> 23093224

Nature or nurture? Determining the heritability of human striatal dopamine function: an [18F]-DOPA PET study.

Paul R A Stokes1, Paul Shotbolt, Mitul A Mehta, Eric Turkheimer, Aaf Benecke, Caroline Copeland, Federico E Turkheimer, Anne R Lingford-Hughes, Oliver D Howes.   

Abstract

Striatal dopamine function is important for normal personality, cognitive processes and behavior, and abnormalities are linked to a number of neuropsychiatric disorders. However, no studies have examined the relative influence of genetic inheritance and environmental factors in determining striatal dopamine function. Using [18F]-DOPA positron emission tomography (PET), we sought to determine the heritability of presynaptic striatal dopamine function by comparing variability in uptake values in same sex monozygotic (MZ) twins to dizygotic (DZ) twins. Nine MZ and 10 DZ twin pairs underwent high-resolution [18F]-DOPA PET to assess presynaptic striatal dopamine function. Uptake values for the overall striatum and functional striatal subdivisions were determined by a Patlak analysis using a cerebellar reference region. Heritability, shared environmental effects and non-shared individual-specific effects were estimated using a region of interest (ROI) analysis and a confirmatory parametric analysis. Overall striatal heritability estimates from the ROI and parametric analyses were 0.44 and 0.33, respectively. We found a distinction between striatal heritability in the functional subdivisions, with the greatest heritability estimates occurring in the sensorimotor striatum and the greatest effect of individual-specific environmental factors in the limbic striatum. Our results indicate that variation in overall presynaptic striatal dopamine function is determined by a combination of genetic factors and individual-specific environmental factors, with familial environmental effects having no effect. These findings underline the importance of individual-specific environmental factors for striatal dopaminergic function, particularly in the limbic striatum, with implications for understanding neuropsychiatric disorders such as schizophrenia and addictions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093224      PMCID: PMC3547199          DOI: 10.1038/npp.2012.207

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  39 in total

1.  Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum.

Authors:  S N Haber; J L Fudge; N R McFarland
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

2.  Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration.

Authors:  Drake Morgan; Kathleen A Grant; H Donald Gage; Robert H Mach; Jay R Kaplan; Osric Prioleau; Susan H Nader; Nancy Buchheimer; Richard L Ehrenkaufer; Michael A Nader
Journal:  Nat Neurosci       Date:  2002-02       Impact factor: 24.884

3.  First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.

Authors:  Matthäus Willeit; Nathalie Ginovart; Ariel Graff; Pablo Rusjan; Irina Vitcu; Sylvain Houle; Philip Seeman; Alan A Wilson; Shitij Kapur
Journal:  Neuropsychopharmacology       Date:  2007-04-04       Impact factor: 7.853

4.  Assessment of spatial normalization of PET ligand images using ligand-specific templates.

Authors:  J H Meyer; R N Gunn; R Myers; P M Grasby
Journal:  Neuroimage       Date:  1999-05       Impact factor: 6.556

5.  Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.

Authors:  Lawrence S Kegeles; Anissa Abi-Dargham; W Gordon Frankle; Roberto Gil; Thomas B Cooper; Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Suzanne N Haber; Marc Laruelle
Journal:  Arch Gen Psychiatry       Date:  2010-03

6.  Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking.

Authors:  Albert Gjedde; Yoshitaka Kumakura; Paul Cumming; Jakob Linnet; Arne Møller
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-04       Impact factor: 11.205

7.  Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity.

Authors:  E E Forbes; S M Brown; M Kimak; R E Ferrell; S B Manuck; A R Hariri
Journal:  Mol Psychiatry       Date:  2007-09-25       Impact factor: 15.992

8.  Dopamine release in the human striatum: motor and cognitive tasks revisited.

Authors:  Julia M Lappin; Suzanne J Reeves; Mitul A Mehta; Alice Egerton; Mark Coulson; Paul M Grasby
Journal:  J Cereb Blood Flow Metab       Date:  2008-12-17       Impact factor: 6.200

9.  Variation in dopamine genes influences responsivity of the human reward system.

Authors:  Jean-Claude Dreher; Philip Kohn; Bhaskar Kolachana; Daniel R Weinberger; Karen Faith Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

10.  Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration.

Authors:  Roshan Cools; Michael J Frank; Sasha E Gibbs; Asako Miyakawa; William Jagust; Mark D'Esposito
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

View more
  21 in total

1.  DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum.

Authors:  Mikaeel Valli; Sang Soo Cho; Mario Masellis; Robert Chen; Pablo Rusjan; Jinhee Kim; Yuko Koshimori; Alexander Mihaescu; Antonio P Strafella
Journal:  Mol Neurobiol       Date:  2019-03-08       Impact factor: 5.590

2.  Inheritance of Neural Substrates for Motivation and Pleasure.

Authors:  Zhi Li; Yi Wang; Chao Yan; Eric F C Cheung; Anna R Docherty; Pak C Sham; Raquel E Gur; Ruben C Gur; Raymond C K Chan
Journal:  Psychol Sci       Date:  2019-07-18

3.  Common Variation in the DOPA Decarboxylase (DDC) Gene and Human Striatal DDC Activity In Vivo.

Authors:  Daniel P Eisenberg; Philip D Kohn; Catherine E Hegarty; Angela M Ianni; Bhaskar Kolachana; Michael D Gregory; Joseph C Masdeu; Karen F Berman
Journal:  Neuropsychopharmacology       Date:  2016-02-29       Impact factor: 7.853

4.  Prediction of Neurocognitive Deficits by Parkinsonian Motor Impairment in Schizophrenia: A Study in Neuroleptic-Naïve Subjects, Unaffected First-Degree Relatives and Healthy Controls From an Indigenous Population.

Authors:  Juan L Molina; Gabriela González Alemán; Néstor Florenzano; Eduardo Padilla; María Calvó; Gonzalo Guerrero; Danielle Kamis; Lee Stratton; Juan Toranzo; Beatriz Molina Rangeon; Helena Hernández Cuervo; Mercedes Bourdieu; Manuel Sedó; Sergio Strejilevich; Claude Robert Cloninger; Javier I Escobar; Gabriel A de Erausquin
Journal:  Schizophr Bull       Date:  2016-03-18       Impact factor: 9.306

Review 5.  Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders.

Authors:  Lars Farde; Pontus Plavén-Sigray; Jacqueline Borg; Simon Cervenka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-04-19       Impact factor: 6.237

6.  Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain.

Authors:  J Borg; S Cervenka; R Kuja-Halkola; G J Matheson; E G Jönsson; P Lichtenstein; S Henningsson; T Ichimiya; H Larsson; P Stenkrona; C Halldin; L Farde
Journal:  Mol Psychiatry       Date:  2015-10-06       Impact factor: 15.992

7.  Urbanicity, social adversity and psychosis.

Authors:  Andreas Heinz; Lorenz Deserno; Ulrich Reininghaus
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 8.  Schizophrenia: an integrated sociodevelopmental-cognitive model.

Authors:  Oliver D Howes; Robin M Murray
Journal:  Lancet       Date:  2013-12-06       Impact factor: 79.321

9.  Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.

Authors:  Maria Rogdaki; Céline Devroye; Mariasole Ciampoli; Mattia Veronese; Abhishekh H Ashok; Robert A McCutcheon; Sameer Jauhar; Ilaria Bonoldi; Maria Gudbrandsen; Eileen Daly; Therese van Amelsvoort; Marianne Van Den Bree; Michael J Owen; Federico Turkheimer; Francesco Papaleo; Oliver D Howes
Journal:  Mol Psychiatry       Date:  2021-05-12       Impact factor: 15.992

Review 10.  Glutamate and dopamine in schizophrenia: an update for the 21st century.

Authors:  Oliver Howes; Rob McCutcheon; James Stone
Journal:  J Psychopharmacol       Date:  2015-01-13       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.